View ValuationMcPherson's 将来の成長Future 基準チェック /06現在、 McPherson'sの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Personal Products 収益成長13.6%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Jul 18+ 1 more updateMcPherson's Limited Provides Earnings Guidance for the Full Year Period Ended 30 June 2025McPherson's Limited provided earnings guidance for the full year period ended 30 June 2025. For the year, revenue from continuing operations expected to be in the order of $139.0 million.Price Target Changed • Feb 27Price target increased by 25% to AU$0.67Up from AU$0.54, the current price target is provided by 1 analyst. New target price is 5.9% above last closing price of AU$0.63. Stock is up 1.2% over the past year. The company posted a net loss per share of AU$0.035 last year.Price Target Changed • Sep 01Price target decreased by 14% to AU$0.54Down from AU$0.62, the current price target is an average from 2 analysts. New target price is 14% above last closing price of AU$0.47. Stock is down 41% over the past year. The company is forecast to post earnings per share of AU$0.044 next year compared to a net loss per share of AU$0.035 last year.Major Estimate Revision • May 25Consensus EPS estimates fall by 29%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$213.7m to AU$215.9m. EPS estimate fell from AU$0.046 to AU$0.033 per share. Net income forecast to grow 50% next year vs 33% growth forecast for Personal Products industry in Australia. Consensus price target down from AU$0.72 to AU$0.62. Share price fell 2.6% to AU$0.56 over the past week.Price Target Changed • Mar 28Price target decreased by 7.9% to AU$0.78Down from AU$0.84, the current price target is an average from 2 analysts. New target price is 27% above last closing price of AU$0.61. Stock is down 33% over the past year. The company is forecast to post earnings per share of AU$0.021 for next year compared to AU$0.0026 last year.Price Target Changed • Mar 15Price target decreased by 11% to AU$0.84Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 28% above last closing price of AU$0.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year.すべての更新を表示Recent updatesお知らせ • Feb 25McPherson's Limited (ASX:MCP) announces an Equity Buyback for AUD 2 million worth of its shares.McPherson's Limited (ASX:MCP) announces a share repurchase program. Under the program, the company will repurchase up to AUD 2 million worth of its shares. The purpose of program is to return capital to shareholders, optimize capital management and enhance shareholder value, while retaining sufficient flexibility to support future growth. The program is valid till March 11, 2027. As of February 25, 2026, the company had 143,949,141 shares issued and outstanding.お知らせ • Feb 16McPherson's Limited to Report First Half, 2026 Results on Feb 25, 2026McPherson's Limited announced that they will report first half, 2026 results on Feb 25, 2026分析記事 • Feb 11McPherson's Limited's (ASX:MCP) Share Price Is Matching Sentiment Around Its RevenuesWhen close to half the companies operating in the Personal Products industry in Australia have price-to-sales ratios...お知らせ • Sep 29McPherson's Limited, Annual General Meeting, Oct 31, 2025McPherson's Limited, Annual General Meeting, Oct 31, 2025. Location: thomson geer, level 14, 60 martin place, sydney, nsw, 2000 AustraliaReported Earnings • Aug 28Full year 2025 earnings released: AU$0.12 loss per share (vs AU$0.079 loss in FY 2024)Full year 2025 results: AU$0.12 loss per share (further deteriorated from AU$0.079 loss in FY 2024). Revenue: AU$139.0m (down 3.9% from FY 2024). Net loss: AU$16.6m (loss widened 46% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.お知らせ • Jul 18+ 1 more updateMcPherson's Limited Provides Earnings Guidance for the Full Year Period Ended 30 June 2025McPherson's Limited provided earnings guidance for the full year period ended 30 June 2025. For the year, revenue from continuing operations expected to be in the order of $139.0 million.分析記事 • Jun 30The Market Doesn't Like What It Sees From McPherson's Limited's (ASX:MCP) Revenues YetWith a price-to-sales (or "P/S") ratio of 0.3x McPherson's Limited ( ASX:MCP ) may be sending bullish signals at the...分析記事 • Mar 15McPherson's Limited (ASX:MCP) Not Doing Enough For Some Investors As Its Shares Slump 27%The McPherson's Limited ( ASX:MCP ) share price has fared very poorly over the last month, falling by a substantial...Reported Earnings • Feb 27First half 2025 earnings released: AU$0.006 loss per share (vs AU$0.011 profit in 1H 2024)First half 2025 results: AU$0.006 loss per share (down from AU$0.011 profit in 1H 2024). Revenue: AU$70.7m (down 32% from 1H 2024). Net loss: AU$1.54m (down 197% from profit in 1H 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.お知らせ • Feb 25McPherson's Limited to Report First Half, 2025 Results on Feb 26, 2025McPherson's Limited announced that they will report first half, 2025 results on Feb 26, 2025分析記事 • Dec 20More Unpleasant Surprises Could Be In Store For McPherson's Limited's (ASX:MCP) Shares After Tumbling 26%McPherson's Limited ( ASX:MCP ) shareholders that were waiting for something to happen have been dealt a blow with a...お知らせ • Oct 24McPherson's Limited, Annual General Meeting, Nov 27, 2024McPherson's Limited, Annual General Meeting, Nov 27, 2024. Location: the offices of thomson geer, level 14, 60 martin place, sydney, nsw, 2000., sydney AustraliaNew Risk • Oct 16New major risk - Revenue and earnings growthEarnings have declined by 65% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Market cap is less than US$100m (AU$57.6m market cap, or US$38.6m).Reported Earnings • Aug 30Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023)Full year 2024 results: AU$0.079 loss per share (further deteriorated from AU$0.035 loss in FY 2023). Revenue: AU$144.7m (down 31% from FY 2023). Net loss: AU$11.4m (loss widened 125% from FY 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 6.2% growth forecast for the Global Personal Products industry. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.お知らせ • Aug 21McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024McPherson's Limited announced that they will report fiscal year 2024 results at 10:00 AM, AUS Eastern Standard Time on Aug 29, 2024分析記事 • Aug 01McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding UpThere wouldn't be many who think McPherson's Limited's ( ASX:MCP ) price-to-sales (or "P/S") ratio of 0.3x is worth a...Reported Earnings • Feb 28First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)First half 2024 results: EPS: AU$0.011 (up from AU$0.001 in 1H 2023). Revenue: AU$103.4m (down 7.7% from 1H 2023). Net income: AU$1.58m (up AU$1.50m from 1H 2023). Profit margin: 1.5% (up from 0.1% in 1H 2023). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Global Personal Products industry. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.Price Target Changed • Feb 27Price target increased by 25% to AU$0.67Up from AU$0.54, the current price target is provided by 1 analyst. New target price is 5.9% above last closing price of AU$0.63. Stock is up 1.2% over the past year. The company posted a net loss per share of AU$0.035 last year.Upcoming Dividend • Feb 26Upcoming dividend of AU$0.02 per shareEligible shareholders must have bought the stock before 04 March 2024. Payment date: 22 March 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (2.0%).New Risk • Feb 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (AU$80.6m market cap, or US$52.6m).お知らせ • Dec 18McPherson's Limited Announces Executive ChangesMcPherson's Limited announced that Craig Durham has been appointed as General Counsel & Company Secretary of McPherson's commencing on 15 January 2024. Craig has previously worked in the fast-moving consumer goods industry both in Australiaand in the U.S. Prior to McPherson's, Craig has had extensive executive leadership team and legal and governance experience in both listed and unlisted environments and has worked in highly regulated industries including intelligent traffic systems, gamingtechnology and financial services. Craig holds a current practising certificate in New South Wales and is also admitted in New York, U.S. Craig replaces Linda Gough as company secretary of McPherson's. Paul Witheridge will continue as an appointed company secretary of McPherson's and is the person nominated under ASX Listing Rule 12.6 for communication with the ASX in relation to Listing Rule matters.分析記事 • Dec 18McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch UpMcPherson's Limited ( ASX:MCP ) shareholders would be excited to see that the share price has had a great month...分析記事 • Oct 09Here's Why McPherson's (ASX:MCP) Can Manage Its Debt ResponsiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...お知らせ • Oct 05McPherson's Limited, Annual General Meeting, Nov 28, 2023McPherson's Limited, Annual General Meeting, Nov 28, 2023, at 11:01 AUS Eastern Standard Time. Location: MA Financial Group, Level 27, 10 Carrington Street Sydney AustraliaPrice Target Changed • Sep 01Price target decreased by 14% to AU$0.54Down from AU$0.62, the current price target is an average from 2 analysts. New target price is 14% above last closing price of AU$0.47. Stock is down 41% over the past year. The company is forecast to post earnings per share of AU$0.044 next year compared to a net loss per share of AU$0.035 last year.分析記事 • Aug 28McPherson's (ASX:MCP) Will Pay A Smaller Dividend Than Last YearMcPherson's Limited ( ASX:MCP ) is reducing its dividend from last year's comparable payment to A$0.01 on the 22nd of...Upcoming Dividend • Aug 28Upcoming dividend of AU$0.01 per share at 4.0% yieldEligible shareholders must have bought the stock before 04 September 2023. Payment date: 22 September 2023. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 4.0%. Lower than top quartile of Australian dividend payers (7.1%). Higher than average of industry peers (2.0%).お知らせ • Aug 24McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023McPherson's Limited announced ordinary fully paid dividend of AUD 0.01000000 for the six months ended June 30, 2023 to be paid on September 22, 2023. Ex Date is September 4, 2023. Record Date is September 5, 2023.Reported Earnings • Aug 24Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: AU$0.035 loss per share (down from AU$0.003 profit in FY 2022). Revenue: AU$210.3m (down 1.8% from FY 2022). Net loss: AU$5.06m (down AU$5.39m from profit in FY 2022). Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 8.3% growth forecast for the Personal Products industry in Oceania. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings.お知らせ • Aug 22McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023McPherson's Limited announced that they will report fiscal year 2023 results on Aug 24, 2023Board Change • Aug 02Less than half of directors are independentFollowing MD, CEO & Director Brett Charlton's arrival on 01 August 2023, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Helen Thornton was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.分析記事 • Jul 24A Look At The Fair Value Of McPherson's Limited (ASX:MCP)Key Insights Using the 2 Stage Free Cash Flow to Equity, McPherson's fair value estimate is AU$0.52 McPherson's...お知らせ • Jul 06+ 1 more updateMcPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023McPherson’s Limited announced the appointment of Brett Charlton to the role of Chief Executive Officer (CEO), effective 1 August 2023. Brett joins McPherson’s having recently been an advisor to companies on strategic growth plans in the consumer goods arena. He was previously Chief Skincare Officer for Laser Clinics Australia, and prior to that, was Managing Director for Sanofi Consumer Healthcare and Tip Top Ice Cream. Brett combines 25 years of marketing and branding experience, with strong manufacturing and supply chain expertise with a customer, consumer, digital and data-first orientation. His skills and experience ensure that he develops and leads a team on the journey to sustainable success.Buying Opportunity • Jul 01Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 33%. The fair value is estimated to be AU$0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 5.1% in 2 years. Earnings is forecast to grow by 147% in the next 2 years.お知らせ • Jun 01+ 1 more updateMcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023McPherson's Limited confirms the resignation of Grant Peck, Managing Director and Chief Executive Officer, effective 31 May 2023.Major Estimate Revision • May 25Consensus EPS estimates fall by 29%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$213.7m to AU$215.9m. EPS estimate fell from AU$0.046 to AU$0.033 per share. Net income forecast to grow 50% next year vs 33% growth forecast for Personal Products industry in Australia. Consensus price target down from AU$0.72 to AU$0.62. Share price fell 2.6% to AU$0.56 over the past week.分析記事 • May 17These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Price Target Changed • Mar 28Price target decreased by 7.9% to AU$0.78Down from AU$0.84, the current price target is an average from 2 analysts. New target price is 27% above last closing price of AU$0.61. Stock is down 33% over the past year. The company is forecast to post earnings per share of AU$0.021 for next year compared to AU$0.0026 last year.Buying Opportunity • Mar 20Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 13%. The fair value is estimated to be AU$0.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 6.9% in 2 years. Earnings is forecast to grow by 207% in the next 2 years.Reported Earnings • Mar 15First half 2023 earnings: EPS misses analyst expectationsFirst half 2023 results: EPS: AU$0.001 (up from AU$0.017 loss in 1H 2022). Revenue: AU$112.1m (up 2.9% from 1H 2022). Net income: AU$82.0k (up AU$2.23m from 1H 2022). Profit margin: 0.1% (up from net loss in 1H 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 96%. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 7.7% growth forecast for the Personal Products industry in Oceania. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.Price Target Changed • Mar 15Price target decreased by 11% to AU$0.84Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 28% above last closing price of AU$0.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year.Buying Opportunity • Feb 27Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 17%. The fair value is estimated to be AU$0.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 3.3% per annum. Earnings is also forecast to grow by 41% per annum over the same time period.お知らせ • Jan 23McPherson's Limited Appoints Linda Gough as Company SecretaryMcPherson's Limited announced the appointment of Linda Gough to the role of Company Secretary, effective 16 January 2023. Ms. Gough has over twenty years legal and governance experience, advising listed and non-listed entities in ANZ, Asia and North America, including WPP AUNZ Limited, FairfaxMedia Limited, SAP Australia and George Weston Foods. She holds a Master of Laws from the University of New South Wales, as well as a graduate diploma in governance from the Governance Institute of Australia. Ms. Gough will be responsible for communication with the ASX under Rule 12.6. McPherson's existing Co-Company Secretary, Paul Witheridge, continues in his role.Price Target Changed • Jan 20Price target decreased to AU$0.84Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 16% above last closing price of AU$0.72. Stock is down 12% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year.お知らせ • Jan 17McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023McPherson's Limited announced that they will report first half, 2023 results on Feb 28, 2023Major Estimate Revision • Dec 26Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 EPS estimate fell from AU$0.07 to AU$0.06 per share. Revenue forecast steady at AU$228.2m. Net income forecast to grow 2,573% next year vs 20% growth forecast for Personal Products industry in Australia. Consensus price target broadly unchanged at AU$0.95. Share price rose 6.9% to AU$0.70 over the past week.お知らせ • Oct 26McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022McPherson's Limited announced that Geoffrey Pearce will resign as a Director with effect from the conclusion of the Company's Annual GeneralMeeting, which will be held on 22 November 2022. Mr. Pearce has served on the Board of McPherson's since February 2018.お知らせ • Sep 30McPherson's Limited, Annual General Meeting, Nov 22, 2022McPherson's Limited, Annual General Meeting, Nov 22, 2022, at 11:01 AUS Eastern Standard Time. Location: at the offices of Thomson Geer, Level 14, 60 Martin Place, Sydney, 2000 Sydney AustraliaUpcoming Dividend • Aug 29Upcoming dividend of AU$0.02 per shareEligible shareholders must have bought the stock before 05 September 2022. Payment date: 23 September 2022. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 6.6%. Within top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (1.8%).Reported Earnings • Aug 26Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: AU$0.003 (up from AU$0.042 loss in FY 2021). Revenue: AU$214.2m (up 6.7% from FY 2021). Net income: AU$333.0k (up AU$5.37m from FY 2021). Profit margin: 0.2% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 83%. Over the next year, revenue is forecast to grow 6.1%, compared to a 12% growth forecast for the Personal Products industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.お知らせ • Aug 25McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022Since the 2022 financial year end, the Directors of McPherson's Limited have declared a fully franked final dividend of 2.0 cents per fully paid share (2021: 1.5 cents per fully paid share). The aggregate amount of the dividend to be paid on 23 September 2022 but not recognised as a liability at year end. Record date for determining entitlements to the dividend 6 September 2022.お知らせ • Aug 11McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022McPherson's Limited announced that they will report fiscal year 2022 results on Aug 25, 2022Reported Earnings • Feb 24First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst half 2022 results: AU$0.017 loss per share (down from AU$0.009 profit in 1H 2021). Revenue: AU$108.9m (up 6.8% from 1H 2021). Net loss: AU$2.14m (down 304% from profit in 1H 2021). Revenue missed analyst estimates by 100%. Earnings per share (EPS) exceeded analyst estimates by 649%. Over the next year, revenue is forecast to grow 7.3%, compared to a 20% growth forecast for the industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.お知らせ • Feb 24+ 1 more updateMcpherson's Limited Announces Board ChangesMcPherson's Limited announced appointment of J.M. McKellar as member of the Risk and Compliance Committee on 21 February 2022. A.J. Cook appointed as Chair of the Risk and Compliance Committee on 21 February 2022. H. Thornton was appointed as Chair of the Audit Committee and member of the Risk and Compliance Committee on 21 February 2022. A.J. Cook Resigned as Chair of the Audit, Risk Management and Compliance Committee on 21 February 2022. J.M. McKellar Resigned as member of the Audit, Risk Management and Compliance Committee on 21 February 2022.お知らせ • Feb 22McPherson's Limited Announces Changes to Its BoardMcPherson's Limited announced Mr. Graham Cubbin has retired from the board with effect from February 21, 2022. Mr. Cubbin has served on the board of McPherson's since September 2010, and held the role of chairman from July 1, 2015 until July 21, 2021. Following the appointment of Mr. Ari Mervis as chairman, Mr. Cubbin agreed to remain on the board, and as a member of the Audit, Risk management and compliance committee, which has ensured an orderly and effective transition.お知らせ • Feb 16McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022McPherson's Limited announced that they will report first half, 2022 results on Feb 23, 2022Price Target Changed • Sep 15Price target decreased to AU$1.19Down from AU$1.40, the current price target is an average from 2 analysts. New target price is 9.7% above last closing price of AU$1.09.お知らせ • Jun 15Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.Arrotex Pharmaceuticals Pty Limited made a non-binding indicative offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million on April 28, 2021. Offer will be made by scheme of arrangement. Under the transaction, Offeror will acquire 128.40346 million shares and 3.838 million Performance Right of McPherson's at a price of AUD 1.6 per share in cash. Pre transaction, Investors Mutual Limited holds 5.8 million shares representing 4.5% stake, Microequities Asset Management Pty Limited holds 7.5 million shares representing 5.8% stake, Lennox Capital Partners 8.3 million shares representing 6.9% stake and Kin Group Pty Ltd holds 6.4 million shares representing 4.95% stake in McPherson's. Arrotex Indicative Proposal can be fully funded via a combination of debt and existing Arrotex cash reserves. Arrotex has stated it would be open to the McPherson’s Board declaring a fully franked special dividend payable to shareholders as part of the indicative offer price, subject to ATO approval, prior to completion of an agreed transaction with Arrotex. The Arrotex Indicative Proposal is subject to a number of standard conditions, including completion of satisfactory due diligence within a 4 week period pertaining to accounting, financial, legal and key operational areas; entry into a scheme of implementation agreement on customary terms and conditions, including receipt of a unanimous recommendation from the McPherson’s Board for McPherson’s shareholders to vote in favour of the scheme; a break fee payable by McPherson’s to Arrotex compliant with the Takeovers Panel guidance; subject to the customary fiduciary outs in the event of McPherson’s receiving a superior offer, customary exclusivity arrangements; and final approval of the Arrotex Board and necessary approvals from Arrotex’s debt financier. Arrotex has further communicated that it does not anticipate that indicative proposal will be subject to any material regulatory conditions. Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others on June 15, 2021.Price Target Changed • May 17Price target increased to AU$1.53Up from AU$1.40, the current price target is an average from 3 analysts. New target price is 9.3% above last closing price of AU$1.40.お知らせ • Apr 30Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million on April 28, 2021. Offer will be made by scheme of arrangement. Under the transaction, Offeror will acquire 128.40346 million shares and 3.838 million Performance Right of McPherson's at a price of AUD 1.6 per share in cash. Pre transaction, Investors Mutual Limited holds 5.8 million shares representing 4.5% stake, Microequities Asset Management Pty Limited holds 7.5 million shares representing 5.8% stake, Lennox Capital Partners 8.3 million shares representing 6.9% stake and Kin Group Pty Ltd holds 6.4 million shares representing 4.95% stake in McPherson's. Arrotex Indicative Proposal can be fully funded via a combination of debt and existing Arrotex cash reserves. Arrotex has stated it would be open to the McPherson’s Board declaring a fully-franked special dividend payable to shareholders as part of the indicative offer price, subject to ATO approval, prior to completion of an agreed transaction with Arrotex. The Arrotex Indicative Proposal is subject to a number of standard conditions, including completion of satisfactory due diligence within a 4 week period pertaining to accounting, financial, legal and key operational areas; entry into a scheme of implementation agreement on customary terms and conditions, including receipt of a unanimous recommendation from the McPherson’s Board for McPherson’s shareholders to vote in favour of the scheme; a break fee payable by McPherson’s to Arrotex compliant with the Takeovers Panel guidance; subject to the customary fiduciary outs in the event of McPherson’s receiving a superior offer, customary exclusivity arrangements; and final approval of the Arrotex Board and necessary approvals from Arrotex’s debt financier. Arrotex has further communicated that it does not anticipate that Indicative Proposal will be subject to any material regulatory conditions.お知らせ • Apr 29McPherson's Limited Provides Earnings Guidance for the Full Year 2021McPherson's Limited provides earnings guidance for the full year 2021. The company providing quantitative guidance for fascial year 2021. Total full year sales revenue is forecast to decline from $222 million in fascial year 2020 to the range of $200 million to $205 million in fascial year 2021. Underlying Group fascial year 2021 earnings before interest and tax (EBIT) is forecast to be within a range of $10 million to $13 million; Underlying fascial year 2021 profit after tax is forecast to be in a range of $6 million to $8 million; and Underlying fascial year 2021 EPS is forecast to be in the range of 5.0cps to 6.5cps.お知らせ • Feb 18McPherson's Limited Not Providing Earnings Guidance Due to COVID-19McPherson's Limited announced that There remains an elevated level of uncertainty pertaining to McPherson's short-term trading outlook, largely due to the difficulty of forecasting demand in China. Consumer behaviour will be difficult to gauge in the short term following an unexpected slowdown in the market in the last quarter of last year. It is therefore not possible to provide guidance at this stage, but it remains likely that underlying profit before tax and earnings per share for 2H21 and FY21 will be materially below 2H20 and FY20.お知らせ • Feb 16McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the BoardMcPherson's Limited announced the appointment of Mr. Ari Mervis as an independent, non-executive Director to the Board, effective immediately. McPherson's has sought to appoint an additional non-executive Director with skills and experience to ensure that the Board composition continues to support the company's focused strategy to be a leader in Health, Wellness and Beauty, as well as complement the existing experience base of the Board. Ari has extensive global experience which spans a range of industries in branded goods, consumer staples, agriculture, food and beverages. Ari's recent executive roles have been Executive Chairman of Accolade Wines, MD and CEO of Murray Goulburn, and prior to that he spent 27 years at global brewer SABMiller where his career culminated as CEO of Carlton & United Breweries and MD Asia Pacific – a member of the global leadership team.分析記事 • Feb 12Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?McPherson's Limited ( ASX:MCP ) shareholders might understandably be very concerned that the share price has dropped...お知らせ • Feb 10McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021McPherson's Limited announced that they will report first half, 2021 results on Feb 17, 2021分析記事 • Jan 25Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...分析記事 • Jan 07Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?With its stock down 54% over the past three months, it is easy to disregard McPherson's (ASX:MCP). But if you pay close...分析記事 • Dec 20A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)Today we will run through one way of estimating the intrinsic value of McPherson's Limited ( ASX:MCP ) by estimating...Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improved over the past weekAfter last week's 21% share price gain to AU$1.40, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.3x. This compares to an average P/E of 25x in the Personal Products industry. Total returns to shareholders over the past three years are 47%.お知らせ • Dec 11McPherson's CEO ChangeMcPherson's Limited announced the following key changes to its executive team. Mr. Laurie McAllister has resigned from the Company as Chief Executive Officer and Managing Director, effective 9th December 2020. The Board thanks Mr. McAllister for his service over the past four years, noting that Laurie leaves the Company in a strong position for future growth, having successfully completed the recent Global Therapeutics acquisition, and notwithstanding the challenges arising from the COVID-19 pandemic. Mr. McAllister has agreed to remain available to the Company for a period following his resignation and to assist the Company and the McPherson's executive team as may be required. Mr. Grant Peck, who has been a non-executive Director on the McPherson's board since December 2017, will replace Mr. McAllister in the role of Chief Executive Officer and Managing Director on an interim basis, effective today. This will provide continuity and aid the transition to a new permanent CEO and Managing Director.Valuation Update With 7 Day Price Move • Dec 10Market pulls back on stock over the past weekAfter last week's 18% share price decline to AU$1.15, the stock is trading at a trailing P/E ratio of 20.3x, down from the previous P/E ratio of 24.7x. This compares to an average P/E of 25x in the Personal Products industry. Total returns to shareholders over the past three years are 31%.Is New 90 Day High Low • Dec 10New 90-day low: AU$1.15The company is down 61% from its price of AU$2.92 on 11 September 2020. The Australian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$1.58 per share.分析記事 • Dec 03Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts DramaticallyMarket forces rained on the parade of McPherson's Limited ( ASX:MCP ) shareholders today, when the analysts downgraded...Price Target Changed • Dec 02Price target lowered to AU$2.36Down from AU$3.27, the current price target is an average from 4 analysts. The new target price is 89% above the current share price of AU$1.25. As of last close, the stock is down 48% over the past year.Major Estimate Revision • Dec 02Analysts lower EPS estimates to AU$0.083The 2021 consensus revenue estimate was lowered from AU$244.8m to AU$226.5m. Earning per share (EPS) estimate was also lowered from AU$0.14 to AU$0.083 for the same period. Net income is expected to grow by 95% next year compared to 25% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.27 to AU$2.36. Share price is down by 40% to AU$1.25 over the past week.Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 16% share price decline to AU$1.83, the stock is trading at a trailing P/E ratio of 32.2x, down from the previous P/E ratio of 38.2x. This compares to an average P/E of 26x in the Personal Products industry. Total returns to shareholders over the past three years are 102%.分析記事 • Nov 22Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend YieldDividend paying stocks like McPherson's Limited (ASX:MCP) tend to be popular with investors, and for good reason...Is New 90 Day High Low • Nov 18New 90-day low: AU$2.18The company is down 26% from its price of AU$2.95 on 20 August 2020. The Australian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.67 per share.Major Estimate Revision • Oct 30Analysts update estimatesThe 2021 consensus revenue estimate increased from AU$233.4m to AU$238.9m. Earnings per share (EPS) estimate was lowered from AU$0.16 to AU$0.14 for the same period. Net income is expected to grow by 164% next year compared to 20% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.55 to AU$3.51. Share price is down by 10% to AU$2.27 over the past week.お知らせ • Oct 29McPherson's Limited has completed a Follow-on Equity Offering in the amount of AUD 36.547 million.McPherson's Limited has completed a Follow-on Equity Offering in the amount of AUD 36.547 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 16,100,000 Price\Range: AUD 2.27 Discount Per Security: AUD 0.0454 Transaction Features: Subsequent Direct ListingMajor Estimate Revision • Oct 28Analysts update estimatesThe 2021 consensus earning per share (EPS) estimate was lowered from AU$0.17 to AU$0.15. Revenue estimate was approximately flat at AU$236.9m. Net income is expected to grow by 174% next year compared to 21% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.55 to AU$3.51. Share price is down by 14% to AU$2.28 over the past week.Is New 90 Day High Low • Oct 21New 90-day low: AU$2.64The company is down 12% from its price of AU$3.00 on 23 July 2020. The Australian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.85 per share.分析記事 • Sep 10Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...分析記事 • Aug 19Here's What McPherson's Limited's (ASX:MCP) Shareholder Ownership Structure Looks LikeIf you want to know who really controls McPherson's Limited (ASX:MCP), then you'll have to look at the makeup of its...お知らせ • Aug 07McPherson's Limited to Report Fiscal Year 2020 Results on Aug 19, 2020McPherson's Limited announced that they will report fiscal year 2020 results at 6:19 AM, GMT Standard Time on Aug 19, 2020分析記事 • Jul 30McPherson's Limited (ASX:MCP) P/E Isn't Throwing Up SurprisesWith a price-to-earnings (or "P/E") ratio of 22.5x McPherson's Limited (ASX:MCP) may be sending bearish signals at the...分析記事 • Jul 15Is McPherson's Limited (ASX:MCP) Expensive For A Reason? A Look At Its Intrinsic ValueDoes the July share price for McPherson's Limited (ASX:MCP) reflect what it's really worth? Today, we will estimate... このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、McPherson's は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測ASX:MCP - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025134-1746N/A9/30/2025137-1724N/A6/30/2025139-17-12N/A3/31/2025139-1515N/A12/31/2024139-1338N/A9/30/2024142-12710N/A6/30/2024145-111012N/A12/31/2023120-11819N/A9/30/2023137-11113N/A6/30/2023155-157N/A3/31/2023214-157N/A12/31/2022217368N/A9/30/202221611113N/A6/30/202221401619N/A3/31/2022211-4N/AN/AN/A12/31/2021208-958N/A9/30/2021204-735N/A6/30/2021201-503N/A3/31/2021210-2N/AN/AN/A12/31/202021811618N/A9/30/202022141718N/A6/30/202022361819N/A3/31/2020216101921N/A12/31/2019210142023N/A9/30/201921014N/A21N/A6/30/201921014N/A20N/A3/31/201921112N/AN/AN/A12/31/201821111N/A-4N/A9/30/201821111N/A1N/A6/30/201821111N/A7N/A3/31/201820710N/A14N/A12/31/20172038N/A21N/A9/30/20172084N/A23N/A6/30/20172120N/A24N/A3/31/2017235-1N/A33N/A12/31/2016259-1N/A42N/A9/30/20162865N/A34N/A6/30/201631311N/A25N/A3/31/201632310N/AN/AN/A12/31/201533310N/A-11N/A9/30/20153419N/A-2N/A6/30/20153509N/A7N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MCPの予測収益成長が 貯蓄率 ( 3.6% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: MCPの収益がAustralian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: MCPの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: MCPの収益がAustralian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: MCPの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MCPの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 15:26終値2026/05/22 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋McPherson's Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Elijah MayrCLSASarah MannMA Moelis Australia Securities Pty LtdJosephine LittleMorgans Financial Limited2 その他のアナリストを表示
お知らせ • Jul 18+ 1 more updateMcPherson's Limited Provides Earnings Guidance for the Full Year Period Ended 30 June 2025McPherson's Limited provided earnings guidance for the full year period ended 30 June 2025. For the year, revenue from continuing operations expected to be in the order of $139.0 million.
Price Target Changed • Feb 27Price target increased by 25% to AU$0.67Up from AU$0.54, the current price target is provided by 1 analyst. New target price is 5.9% above last closing price of AU$0.63. Stock is up 1.2% over the past year. The company posted a net loss per share of AU$0.035 last year.
Price Target Changed • Sep 01Price target decreased by 14% to AU$0.54Down from AU$0.62, the current price target is an average from 2 analysts. New target price is 14% above last closing price of AU$0.47. Stock is down 41% over the past year. The company is forecast to post earnings per share of AU$0.044 next year compared to a net loss per share of AU$0.035 last year.
Major Estimate Revision • May 25Consensus EPS estimates fall by 29%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$213.7m to AU$215.9m. EPS estimate fell from AU$0.046 to AU$0.033 per share. Net income forecast to grow 50% next year vs 33% growth forecast for Personal Products industry in Australia. Consensus price target down from AU$0.72 to AU$0.62. Share price fell 2.6% to AU$0.56 over the past week.
Price Target Changed • Mar 28Price target decreased by 7.9% to AU$0.78Down from AU$0.84, the current price target is an average from 2 analysts. New target price is 27% above last closing price of AU$0.61. Stock is down 33% over the past year. The company is forecast to post earnings per share of AU$0.021 for next year compared to AU$0.0026 last year.
Price Target Changed • Mar 15Price target decreased by 11% to AU$0.84Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 28% above last closing price of AU$0.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year.
お知らせ • Feb 25McPherson's Limited (ASX:MCP) announces an Equity Buyback for AUD 2 million worth of its shares.McPherson's Limited (ASX:MCP) announces a share repurchase program. Under the program, the company will repurchase up to AUD 2 million worth of its shares. The purpose of program is to return capital to shareholders, optimize capital management and enhance shareholder value, while retaining sufficient flexibility to support future growth. The program is valid till March 11, 2027. As of February 25, 2026, the company had 143,949,141 shares issued and outstanding.
お知らせ • Feb 16McPherson's Limited to Report First Half, 2026 Results on Feb 25, 2026McPherson's Limited announced that they will report first half, 2026 results on Feb 25, 2026
分析記事 • Feb 11McPherson's Limited's (ASX:MCP) Share Price Is Matching Sentiment Around Its RevenuesWhen close to half the companies operating in the Personal Products industry in Australia have price-to-sales ratios...
お知らせ • Sep 29McPherson's Limited, Annual General Meeting, Oct 31, 2025McPherson's Limited, Annual General Meeting, Oct 31, 2025. Location: thomson geer, level 14, 60 martin place, sydney, nsw, 2000 Australia
Reported Earnings • Aug 28Full year 2025 earnings released: AU$0.12 loss per share (vs AU$0.079 loss in FY 2024)Full year 2025 results: AU$0.12 loss per share (further deteriorated from AU$0.079 loss in FY 2024). Revenue: AU$139.0m (down 3.9% from FY 2024). Net loss: AU$16.6m (loss widened 46% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
お知らせ • Jul 18+ 1 more updateMcPherson's Limited Provides Earnings Guidance for the Full Year Period Ended 30 June 2025McPherson's Limited provided earnings guidance for the full year period ended 30 June 2025. For the year, revenue from continuing operations expected to be in the order of $139.0 million.
分析記事 • Jun 30The Market Doesn't Like What It Sees From McPherson's Limited's (ASX:MCP) Revenues YetWith a price-to-sales (or "P/S") ratio of 0.3x McPherson's Limited ( ASX:MCP ) may be sending bullish signals at the...
分析記事 • Mar 15McPherson's Limited (ASX:MCP) Not Doing Enough For Some Investors As Its Shares Slump 27%The McPherson's Limited ( ASX:MCP ) share price has fared very poorly over the last month, falling by a substantial...
Reported Earnings • Feb 27First half 2025 earnings released: AU$0.006 loss per share (vs AU$0.011 profit in 1H 2024)First half 2025 results: AU$0.006 loss per share (down from AU$0.011 profit in 1H 2024). Revenue: AU$70.7m (down 32% from 1H 2024). Net loss: AU$1.54m (down 197% from profit in 1H 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 25McPherson's Limited to Report First Half, 2025 Results on Feb 26, 2025McPherson's Limited announced that they will report first half, 2025 results on Feb 26, 2025
分析記事 • Dec 20More Unpleasant Surprises Could Be In Store For McPherson's Limited's (ASX:MCP) Shares After Tumbling 26%McPherson's Limited ( ASX:MCP ) shareholders that were waiting for something to happen have been dealt a blow with a...
お知らせ • Oct 24McPherson's Limited, Annual General Meeting, Nov 27, 2024McPherson's Limited, Annual General Meeting, Nov 27, 2024. Location: the offices of thomson geer, level 14, 60 martin place, sydney, nsw, 2000., sydney Australia
New Risk • Oct 16New major risk - Revenue and earnings growthEarnings have declined by 65% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Market cap is less than US$100m (AU$57.6m market cap, or US$38.6m).
Reported Earnings • Aug 30Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023)Full year 2024 results: AU$0.079 loss per share (further deteriorated from AU$0.035 loss in FY 2023). Revenue: AU$144.7m (down 31% from FY 2023). Net loss: AU$11.4m (loss widened 125% from FY 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 6.2% growth forecast for the Global Personal Products industry. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings.
お知らせ • Aug 21McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024McPherson's Limited announced that they will report fiscal year 2024 results at 10:00 AM, AUS Eastern Standard Time on Aug 29, 2024
分析記事 • Aug 01McPherson's Limited's (ASX:MCP) Share Price Not Quite Adding UpThere wouldn't be many who think McPherson's Limited's ( ASX:MCP ) price-to-sales (or "P/S") ratio of 0.3x is worth a...
Reported Earnings • Feb 28First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023)First half 2024 results: EPS: AU$0.011 (up from AU$0.001 in 1H 2023). Revenue: AU$103.4m (down 7.7% from 1H 2023). Net income: AU$1.58m (up AU$1.50m from 1H 2023). Profit margin: 1.5% (up from 0.1% in 1H 2023). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Global Personal Products industry. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
Price Target Changed • Feb 27Price target increased by 25% to AU$0.67Up from AU$0.54, the current price target is provided by 1 analyst. New target price is 5.9% above last closing price of AU$0.63. Stock is up 1.2% over the past year. The company posted a net loss per share of AU$0.035 last year.
Upcoming Dividend • Feb 26Upcoming dividend of AU$0.02 per shareEligible shareholders must have bought the stock before 04 March 2024. Payment date: 22 March 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (2.0%).
New Risk • Feb 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (AU$80.6m market cap, or US$52.6m).
お知らせ • Dec 18McPherson's Limited Announces Executive ChangesMcPherson's Limited announced that Craig Durham has been appointed as General Counsel & Company Secretary of McPherson's commencing on 15 January 2024. Craig has previously worked in the fast-moving consumer goods industry both in Australiaand in the U.S. Prior to McPherson's, Craig has had extensive executive leadership team and legal and governance experience in both listed and unlisted environments and has worked in highly regulated industries including intelligent traffic systems, gamingtechnology and financial services. Craig holds a current practising certificate in New South Wales and is also admitted in New York, U.S. Craig replaces Linda Gough as company secretary of McPherson's. Paul Witheridge will continue as an appointed company secretary of McPherson's and is the person nominated under ASX Listing Rule 12.6 for communication with the ASX in relation to Listing Rule matters.
分析記事 • Dec 18McPherson's Limited's (ASX:MCP) Shares Climb 35% But Its Business Is Yet to Catch UpMcPherson's Limited ( ASX:MCP ) shareholders would be excited to see that the share price has had a great month...
分析記事 • Oct 09Here's Why McPherson's (ASX:MCP) Can Manage Its Debt ResponsiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
お知らせ • Oct 05McPherson's Limited, Annual General Meeting, Nov 28, 2023McPherson's Limited, Annual General Meeting, Nov 28, 2023, at 11:01 AUS Eastern Standard Time. Location: MA Financial Group, Level 27, 10 Carrington Street Sydney Australia
Price Target Changed • Sep 01Price target decreased by 14% to AU$0.54Down from AU$0.62, the current price target is an average from 2 analysts. New target price is 14% above last closing price of AU$0.47. Stock is down 41% over the past year. The company is forecast to post earnings per share of AU$0.044 next year compared to a net loss per share of AU$0.035 last year.
分析記事 • Aug 28McPherson's (ASX:MCP) Will Pay A Smaller Dividend Than Last YearMcPherson's Limited ( ASX:MCP ) is reducing its dividend from last year's comparable payment to A$0.01 on the 22nd of...
Upcoming Dividend • Aug 28Upcoming dividend of AU$0.01 per share at 4.0% yieldEligible shareholders must have bought the stock before 04 September 2023. Payment date: 22 September 2023. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 4.0%. Lower than top quartile of Australian dividend payers (7.1%). Higher than average of industry peers (2.0%).
お知らせ • Aug 24McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023McPherson's Limited announced ordinary fully paid dividend of AUD 0.01000000 for the six months ended June 30, 2023 to be paid on September 22, 2023. Ex Date is September 4, 2023. Record Date is September 5, 2023.
Reported Earnings • Aug 24Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: AU$0.035 loss per share (down from AU$0.003 profit in FY 2022). Revenue: AU$210.3m (down 1.8% from FY 2022). Net loss: AU$5.06m (down AU$5.39m from profit in FY 2022). Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 8.3% growth forecast for the Personal Products industry in Oceania. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings.
お知らせ • Aug 22McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023McPherson's Limited announced that they will report fiscal year 2023 results on Aug 24, 2023
Board Change • Aug 02Less than half of directors are independentFollowing MD, CEO & Director Brett Charlton's arrival on 01 August 2023, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Helen Thornton was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
分析記事 • Jul 24A Look At The Fair Value Of McPherson's Limited (ASX:MCP)Key Insights Using the 2 Stage Free Cash Flow to Equity, McPherson's fair value estimate is AU$0.52 McPherson's...
お知らせ • Jul 06+ 1 more updateMcPherson’s Limited Appoints Brett Charlton as Chief Executive Officer, Effective 1 August 2023McPherson’s Limited announced the appointment of Brett Charlton to the role of Chief Executive Officer (CEO), effective 1 August 2023. Brett joins McPherson’s having recently been an advisor to companies on strategic growth plans in the consumer goods arena. He was previously Chief Skincare Officer for Laser Clinics Australia, and prior to that, was Managing Director for Sanofi Consumer Healthcare and Tip Top Ice Cream. Brett combines 25 years of marketing and branding experience, with strong manufacturing and supply chain expertise with a customer, consumer, digital and data-first orientation. His skills and experience ensure that he develops and leads a team on the journey to sustainable success.
Buying Opportunity • Jul 01Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 33%. The fair value is estimated to be AU$0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 5.1% in 2 years. Earnings is forecast to grow by 147% in the next 2 years.
お知らせ • Jun 01+ 1 more updateMcpherson's Limited Announces Resignation of Grant Peck as Chief Executive Officer, Effective 31 May 2023McPherson's Limited confirms the resignation of Grant Peck, Managing Director and Chief Executive Officer, effective 31 May 2023.
Major Estimate Revision • May 25Consensus EPS estimates fall by 29%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$213.7m to AU$215.9m. EPS estimate fell from AU$0.046 to AU$0.033 per share. Net income forecast to grow 50% next year vs 33% growth forecast for Personal Products industry in Australia. Consensus price target down from AU$0.72 to AU$0.62. Share price fell 2.6% to AU$0.56 over the past week.
分析記事 • May 17These 4 Measures Indicate That McPherson's (ASX:MCP) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Price Target Changed • Mar 28Price target decreased by 7.9% to AU$0.78Down from AU$0.84, the current price target is an average from 2 analysts. New target price is 27% above last closing price of AU$0.61. Stock is down 33% over the past year. The company is forecast to post earnings per share of AU$0.021 for next year compared to AU$0.0026 last year.
Buying Opportunity • Mar 20Now 24% undervalued after recent price dropOver the last 90 days, the stock is down 13%. The fair value is estimated to be AU$0.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 6.9% in 2 years. Earnings is forecast to grow by 207% in the next 2 years.
Reported Earnings • Mar 15First half 2023 earnings: EPS misses analyst expectationsFirst half 2023 results: EPS: AU$0.001 (up from AU$0.017 loss in 1H 2022). Revenue: AU$112.1m (up 2.9% from 1H 2022). Net income: AU$82.0k (up AU$2.23m from 1H 2022). Profit margin: 0.1% (up from net loss in 1H 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 96%. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 7.7% growth forecast for the Personal Products industry in Oceania. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
Price Target Changed • Mar 15Price target decreased by 11% to AU$0.84Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 28% above last closing price of AU$0.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year.
Buying Opportunity • Feb 27Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 17%. The fair value is estimated to be AU$0.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 3.3% per annum. Earnings is also forecast to grow by 41% per annum over the same time period.
お知らせ • Jan 23McPherson's Limited Appoints Linda Gough as Company SecretaryMcPherson's Limited announced the appointment of Linda Gough to the role of Company Secretary, effective 16 January 2023. Ms. Gough has over twenty years legal and governance experience, advising listed and non-listed entities in ANZ, Asia and North America, including WPP AUNZ Limited, FairfaxMedia Limited, SAP Australia and George Weston Foods. She holds a Master of Laws from the University of New South Wales, as well as a graduate diploma in governance from the Governance Institute of Australia. Ms. Gough will be responsible for communication with the ASX under Rule 12.6. McPherson's existing Co-Company Secretary, Paul Witheridge, continues in his role.
Price Target Changed • Jan 20Price target decreased to AU$0.84Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 16% above last closing price of AU$0.72. Stock is down 12% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year.
お知らせ • Jan 17McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023McPherson's Limited announced that they will report first half, 2023 results on Feb 28, 2023
Major Estimate Revision • Dec 26Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 EPS estimate fell from AU$0.07 to AU$0.06 per share. Revenue forecast steady at AU$228.2m. Net income forecast to grow 2,573% next year vs 20% growth forecast for Personal Products industry in Australia. Consensus price target broadly unchanged at AU$0.95. Share price rose 6.9% to AU$0.70 over the past week.
お知らせ • Oct 26McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022McPherson's Limited announced that Geoffrey Pearce will resign as a Director with effect from the conclusion of the Company's Annual GeneralMeeting, which will be held on 22 November 2022. Mr. Pearce has served on the Board of McPherson's since February 2018.
お知らせ • Sep 30McPherson's Limited, Annual General Meeting, Nov 22, 2022McPherson's Limited, Annual General Meeting, Nov 22, 2022, at 11:01 AUS Eastern Standard Time. Location: at the offices of Thomson Geer, Level 14, 60 Martin Place, Sydney, 2000 Sydney Australia
Upcoming Dividend • Aug 29Upcoming dividend of AU$0.02 per shareEligible shareholders must have bought the stock before 05 September 2022. Payment date: 23 September 2022. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 6.6%. Within top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (1.8%).
Reported Earnings • Aug 26Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: AU$0.003 (up from AU$0.042 loss in FY 2021). Revenue: AU$214.2m (up 6.7% from FY 2021). Net income: AU$333.0k (up AU$5.37m from FY 2021). Profit margin: 0.2% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 83%. Over the next year, revenue is forecast to grow 6.1%, compared to a 12% growth forecast for the Personal Products industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 25McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022Since the 2022 financial year end, the Directors of McPherson's Limited have declared a fully franked final dividend of 2.0 cents per fully paid share (2021: 1.5 cents per fully paid share). The aggregate amount of the dividend to be paid on 23 September 2022 but not recognised as a liability at year end. Record date for determining entitlements to the dividend 6 September 2022.
お知らせ • Aug 11McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022McPherson's Limited announced that they will report fiscal year 2022 results on Aug 25, 2022
Reported Earnings • Feb 24First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst half 2022 results: AU$0.017 loss per share (down from AU$0.009 profit in 1H 2021). Revenue: AU$108.9m (up 6.8% from 1H 2021). Net loss: AU$2.14m (down 304% from profit in 1H 2021). Revenue missed analyst estimates by 100%. Earnings per share (EPS) exceeded analyst estimates by 649%. Over the next year, revenue is forecast to grow 7.3%, compared to a 20% growth forecast for the industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 24+ 1 more updateMcpherson's Limited Announces Board ChangesMcPherson's Limited announced appointment of J.M. McKellar as member of the Risk and Compliance Committee on 21 February 2022. A.J. Cook appointed as Chair of the Risk and Compliance Committee on 21 February 2022. H. Thornton was appointed as Chair of the Audit Committee and member of the Risk and Compliance Committee on 21 February 2022. A.J. Cook Resigned as Chair of the Audit, Risk Management and Compliance Committee on 21 February 2022. J.M. McKellar Resigned as member of the Audit, Risk Management and Compliance Committee on 21 February 2022.
お知らせ • Feb 22McPherson's Limited Announces Changes to Its BoardMcPherson's Limited announced Mr. Graham Cubbin has retired from the board with effect from February 21, 2022. Mr. Cubbin has served on the board of McPherson's since September 2010, and held the role of chairman from July 1, 2015 until July 21, 2021. Following the appointment of Mr. Ari Mervis as chairman, Mr. Cubbin agreed to remain on the board, and as a member of the Audit, Risk management and compliance committee, which has ensured an orderly and effective transition.
お知らせ • Feb 16McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022McPherson's Limited announced that they will report first half, 2022 results on Feb 23, 2022
Price Target Changed • Sep 15Price target decreased to AU$1.19Down from AU$1.40, the current price target is an average from 2 analysts. New target price is 9.7% above last closing price of AU$1.09.
お知らせ • Jun 15Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others.Arrotex Pharmaceuticals Pty Limited made a non-binding indicative offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million on April 28, 2021. Offer will be made by scheme of arrangement. Under the transaction, Offeror will acquire 128.40346 million shares and 3.838 million Performance Right of McPherson's at a price of AUD 1.6 per share in cash. Pre transaction, Investors Mutual Limited holds 5.8 million shares representing 4.5% stake, Microequities Asset Management Pty Limited holds 7.5 million shares representing 5.8% stake, Lennox Capital Partners 8.3 million shares representing 6.9% stake and Kin Group Pty Ltd holds 6.4 million shares representing 4.95% stake in McPherson's. Arrotex Indicative Proposal can be fully funded via a combination of debt and existing Arrotex cash reserves. Arrotex has stated it would be open to the McPherson’s Board declaring a fully franked special dividend payable to shareholders as part of the indicative offer price, subject to ATO approval, prior to completion of an agreed transaction with Arrotex. The Arrotex Indicative Proposal is subject to a number of standard conditions, including completion of satisfactory due diligence within a 4 week period pertaining to accounting, financial, legal and key operational areas; entry into a scheme of implementation agreement on customary terms and conditions, including receipt of a unanimous recommendation from the McPherson’s Board for McPherson’s shareholders to vote in favour of the scheme; a break fee payable by McPherson’s to Arrotex compliant with the Takeovers Panel guidance; subject to the customary fiduciary outs in the event of McPherson’s receiving a superior offer, customary exclusivity arrangements; and final approval of the Arrotex Board and necessary approvals from Arrotex’s debt financier. Arrotex has further communicated that it does not anticipate that indicative proposal will be subject to any material regulatory conditions. Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others on June 15, 2021.
Price Target Changed • May 17Price target increased to AU$1.53Up from AU$1.40, the current price target is an average from 3 analysts. New target price is 9.3% above last closing price of AU$1.40.
お知らせ • Apr 30Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million.Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million on April 28, 2021. Offer will be made by scheme of arrangement. Under the transaction, Offeror will acquire 128.40346 million shares and 3.838 million Performance Right of McPherson's at a price of AUD 1.6 per share in cash. Pre transaction, Investors Mutual Limited holds 5.8 million shares representing 4.5% stake, Microequities Asset Management Pty Limited holds 7.5 million shares representing 5.8% stake, Lennox Capital Partners 8.3 million shares representing 6.9% stake and Kin Group Pty Ltd holds 6.4 million shares representing 4.95% stake in McPherson's. Arrotex Indicative Proposal can be fully funded via a combination of debt and existing Arrotex cash reserves. Arrotex has stated it would be open to the McPherson’s Board declaring a fully-franked special dividend payable to shareholders as part of the indicative offer price, subject to ATO approval, prior to completion of an agreed transaction with Arrotex. The Arrotex Indicative Proposal is subject to a number of standard conditions, including completion of satisfactory due diligence within a 4 week period pertaining to accounting, financial, legal and key operational areas; entry into a scheme of implementation agreement on customary terms and conditions, including receipt of a unanimous recommendation from the McPherson’s Board for McPherson’s shareholders to vote in favour of the scheme; a break fee payable by McPherson’s to Arrotex compliant with the Takeovers Panel guidance; subject to the customary fiduciary outs in the event of McPherson’s receiving a superior offer, customary exclusivity arrangements; and final approval of the Arrotex Board and necessary approvals from Arrotex’s debt financier. Arrotex has further communicated that it does not anticipate that Indicative Proposal will be subject to any material regulatory conditions.
お知らせ • Apr 29McPherson's Limited Provides Earnings Guidance for the Full Year 2021McPherson's Limited provides earnings guidance for the full year 2021. The company providing quantitative guidance for fascial year 2021. Total full year sales revenue is forecast to decline from $222 million in fascial year 2020 to the range of $200 million to $205 million in fascial year 2021. Underlying Group fascial year 2021 earnings before interest and tax (EBIT) is forecast to be within a range of $10 million to $13 million; Underlying fascial year 2021 profit after tax is forecast to be in a range of $6 million to $8 million; and Underlying fascial year 2021 EPS is forecast to be in the range of 5.0cps to 6.5cps.
お知らせ • Feb 18McPherson's Limited Not Providing Earnings Guidance Due to COVID-19McPherson's Limited announced that There remains an elevated level of uncertainty pertaining to McPherson's short-term trading outlook, largely due to the difficulty of forecasting demand in China. Consumer behaviour will be difficult to gauge in the short term following an unexpected slowdown in the market in the last quarter of last year. It is therefore not possible to provide guidance at this stage, but it remains likely that underlying profit before tax and earnings per share for 2H21 and FY21 will be materially below 2H20 and FY20.
お知らせ • Feb 16McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the BoardMcPherson's Limited announced the appointment of Mr. Ari Mervis as an independent, non-executive Director to the Board, effective immediately. McPherson's has sought to appoint an additional non-executive Director with skills and experience to ensure that the Board composition continues to support the company's focused strategy to be a leader in Health, Wellness and Beauty, as well as complement the existing experience base of the Board. Ari has extensive global experience which spans a range of industries in branded goods, consumer staples, agriculture, food and beverages. Ari's recent executive roles have been Executive Chairman of Accolade Wines, MD and CEO of Murray Goulburn, and prior to that he spent 27 years at global brewer SABMiller where his career culminated as CEO of Carlton & United Breweries and MD Asia Pacific – a member of the global leadership team.
分析記事 • Feb 12Did You Participate In Any Of McPherson's' (ASX:MCP) Fantastic 149% Return ?McPherson's Limited ( ASX:MCP ) shareholders might understandably be very concerned that the share price has dropped...
お知らせ • Feb 10McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021McPherson's Limited announced that they will report first half, 2021 results on Feb 17, 2021
分析記事 • Jan 25Are McPherson's's (ASX:MCP) Statutory Earnings A Good Guide To Its Underlying Profitability?Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
分析記事 • Jan 07Declining Stock and Decent Financials: Is The Market Wrong About McPherson's Limited (ASX:MCP)?With its stock down 54% over the past three months, it is easy to disregard McPherson's (ASX:MCP). But if you pay close...
分析記事 • Dec 20A Look At The Intrinsic Value Of McPherson's Limited (ASX:MCP)Today we will run through one way of estimating the intrinsic value of McPherson's Limited ( ASX:MCP ) by estimating...
Valuation Update With 7 Day Price Move • Dec 17Investor sentiment improved over the past weekAfter last week's 21% share price gain to AU$1.40, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.3x. This compares to an average P/E of 25x in the Personal Products industry. Total returns to shareholders over the past three years are 47%.
お知らせ • Dec 11McPherson's CEO ChangeMcPherson's Limited announced the following key changes to its executive team. Mr. Laurie McAllister has resigned from the Company as Chief Executive Officer and Managing Director, effective 9th December 2020. The Board thanks Mr. McAllister for his service over the past four years, noting that Laurie leaves the Company in a strong position for future growth, having successfully completed the recent Global Therapeutics acquisition, and notwithstanding the challenges arising from the COVID-19 pandemic. Mr. McAllister has agreed to remain available to the Company for a period following his resignation and to assist the Company and the McPherson's executive team as may be required. Mr. Grant Peck, who has been a non-executive Director on the McPherson's board since December 2017, will replace Mr. McAllister in the role of Chief Executive Officer and Managing Director on an interim basis, effective today. This will provide continuity and aid the transition to a new permanent CEO and Managing Director.
Valuation Update With 7 Day Price Move • Dec 10Market pulls back on stock over the past weekAfter last week's 18% share price decline to AU$1.15, the stock is trading at a trailing P/E ratio of 20.3x, down from the previous P/E ratio of 24.7x. This compares to an average P/E of 25x in the Personal Products industry. Total returns to shareholders over the past three years are 31%.
Is New 90 Day High Low • Dec 10New 90-day low: AU$1.15The company is down 61% from its price of AU$2.92 on 11 September 2020. The Australian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$1.58 per share.
分析記事 • Dec 03Analysts Just Shaved Their McPherson's Limited (ASX:MCP) Forecasts DramaticallyMarket forces rained on the parade of McPherson's Limited ( ASX:MCP ) shareholders today, when the analysts downgraded...
Price Target Changed • Dec 02Price target lowered to AU$2.36Down from AU$3.27, the current price target is an average from 4 analysts. The new target price is 89% above the current share price of AU$1.25. As of last close, the stock is down 48% over the past year.
Major Estimate Revision • Dec 02Analysts lower EPS estimates to AU$0.083The 2021 consensus revenue estimate was lowered from AU$244.8m to AU$226.5m. Earning per share (EPS) estimate was also lowered from AU$0.14 to AU$0.083 for the same period. Net income is expected to grow by 95% next year compared to 25% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.27 to AU$2.36. Share price is down by 40% to AU$1.25 over the past week.
Valuation Update With 7 Day Price Move • Nov 30Market pulls back on stock over the past weekAfter last week's 16% share price decline to AU$1.83, the stock is trading at a trailing P/E ratio of 32.2x, down from the previous P/E ratio of 38.2x. This compares to an average P/E of 26x in the Personal Products industry. Total returns to shareholders over the past three years are 102%.
分析記事 • Nov 22Tread With Caution Around McPherson's Limited's (ASX:MCP) 5.0% Dividend YieldDividend paying stocks like McPherson's Limited (ASX:MCP) tend to be popular with investors, and for good reason...
Is New 90 Day High Low • Nov 18New 90-day low: AU$2.18The company is down 26% from its price of AU$2.95 on 20 August 2020. The Australian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.67 per share.
Major Estimate Revision • Oct 30Analysts update estimatesThe 2021 consensus revenue estimate increased from AU$233.4m to AU$238.9m. Earnings per share (EPS) estimate was lowered from AU$0.16 to AU$0.14 for the same period. Net income is expected to grow by 164% next year compared to 20% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.55 to AU$3.51. Share price is down by 10% to AU$2.27 over the past week.
お知らせ • Oct 29McPherson's Limited has completed a Follow-on Equity Offering in the amount of AUD 36.547 million.McPherson's Limited has completed a Follow-on Equity Offering in the amount of AUD 36.547 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 16,100,000 Price\Range: AUD 2.27 Discount Per Security: AUD 0.0454 Transaction Features: Subsequent Direct Listing
Major Estimate Revision • Oct 28Analysts update estimatesThe 2021 consensus earning per share (EPS) estimate was lowered from AU$0.17 to AU$0.15. Revenue estimate was approximately flat at AU$236.9m. Net income is expected to grow by 174% next year compared to 21% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.55 to AU$3.51. Share price is down by 14% to AU$2.28 over the past week.
Is New 90 Day High Low • Oct 21New 90-day low: AU$2.64The company is down 12% from its price of AU$3.00 on 23 July 2020. The Australian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.85 per share.
分析記事 • Sep 10Have Insiders Been Buying McPherson's Limited (ASX:MCP) Shares This Year?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
分析記事 • Aug 19Here's What McPherson's Limited's (ASX:MCP) Shareholder Ownership Structure Looks LikeIf you want to know who really controls McPherson's Limited (ASX:MCP), then you'll have to look at the makeup of its...
お知らせ • Aug 07McPherson's Limited to Report Fiscal Year 2020 Results on Aug 19, 2020McPherson's Limited announced that they will report fiscal year 2020 results at 6:19 AM, GMT Standard Time on Aug 19, 2020
分析記事 • Jul 30McPherson's Limited (ASX:MCP) P/E Isn't Throwing Up SurprisesWith a price-to-earnings (or "P/E") ratio of 22.5x McPherson's Limited (ASX:MCP) may be sending bearish signals at the...
分析記事 • Jul 15Is McPherson's Limited (ASX:MCP) Expensive For A Reason? A Look At Its Intrinsic ValueDoes the July share price for McPherson's Limited (ASX:MCP) reflect what it's really worth? Today, we will estimate...